Latest news
New heart drug targeting inflammation falls short in clinical trial - Cardiovascular BusinessCardiovascular Business · Thu, 06 Aug 2026 20:22:24 GMTBlood thinner recalled after failed test - Cardiovascular BusinessCardiovascular Business · Mon, 03 Aug 2026 17:24:06 GMTNovo Nordisk’s Heart Drug Suffers a Major Setback. What It Means for the Stock. - Barron'sBarron's · Fri, 31 Jul 2026 17:42:00 GMTNovo drug trial fail deals setback to bid to expand beyond obesity - ReutersReuters · Fri, 31 Jul 2026 07:00:00 GMTNovo setback casts doubt on a new way to treat heart disease - BioPharma DiveBioPharma Dive · Fri, 31 Jul 2026 07:00:00 GMTNovo Nordisk shares dive after heart medicine fails trial, dealing another blow to its pipeline - CNBCCNBC · Fri, 31 Jul 2026 07:00:00 GMTNovo Nordisk’s Market Value Sheds $30 Billion—Here’s Why Shares Are Down - ForbesForbes · Fri, 31 Jul 2026 07:00:00 GMTThe Next Miracle Drug Might Already Be in Your Medicine Cabinet - derekthompson.orgderekthompson.org · Wed, 29 Jul 2026 07:00:00 GMT